Aitor Azkarate - Publications

Applying clinical natural language processing to lung cancer in Spain: a terminology-based panel approach.

Journal: ESMO real world data and digital oncology

Published: July 28, 2026

ARIAN protocol: a phase III study of sacituzumab and zimberelimab for the treatment of patients with non-small cell lung cancer.

Journal: Expert opinion on biological therapy

Published: May 20, 2026

Real-World Insights into Stage I-III Non-Small Cell Lung Cancer in Spain in the Pre-Immunotherapy Era Using AI Techniques: The IntellyLUNG Study.

Journal: Life (Basel, Switzerland)

Published: May 18, 2026

Phase Ib of repotrectinib plus osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 23, 2026

Detection of genomic alterations in liquid biopsies from patients with non-small cell lung cancer using FoundationOne Liquid CDx: a cost-effectiveness analysis.

Journal: Journal of medical economics

Published: October 10, 2024

A real‑world study of clinical characteristics, treatment sequence and outcomes of patients with non-small cell lung cancer and EGFR exon 20 insertion mutations.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: August 20, 2024

External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry.

Journal: Therapeutic advances in medical oncology

Published: February 13, 2021

Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: November 25, 2020

Detection of the EGFR G719S Mutation in Non-small Cell Lung Cancer Using Droplet Digital PCR.

Journal: Frontiers in medicine

Published: August 14, 2020

External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: June 06, 2020

Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry.

Journal: PloS one

Published: April 06, 2020

Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients.

Journal: Cells

Published: January 07, 2020